Inventor
BORCHARDT THOMAS B
US18 patents
⚠️ This page may combine multiple inventors who share the name “BORCHARDT THOMAS B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
9 patentsUS10017517B2Jul 10, 2018
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC41 citations98
US11198697B1Dec 14, 2021
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC29 citations97
US11186584B2Nov 30, 2021
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC28 citations97
US10981923B2Apr 20, 2021
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC32 citations97
US11680069B2Jun 20, 2023
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC6 citations93
US11661425B2May 30, 2023
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC9 citations93
US11512092B2Nov 29, 2022
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC21 citations93
US8362014B2Jan 29, 2013
ABT-263 crystalline forms
ABBVIE INC2 citations61
US8759538B1Jun 24, 2014
Crystalline chemotherapeutic
ABBVIE INC0 citations51
ABBOTT LAB
6 patentsUS7960564B2Jun 14, 2011
Crystalline chemotherapeutic
ABBOTT LAB8 citations83
US7378414B2May 27, 2008
Anti-infective agents
ABBOTT LAB17 citations82
US7772404B2Aug 10, 2010
Crystalline form 2 of the chemotherapeutic N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea
ABBOTT LAB8 citations79
US7947843B2May 24, 2011
Crystalline chemotherapeutic
ABBOTT LAB3 citations55
US7994208B2Aug 9, 2011
Crystalline chemotherapeutic
ABBOTT LAB0 citations51
US7538105B2May 26, 2009
Anti-infective agents
ABBOTT LAB0 citations50